|
Post by harryx1 on Jun 4, 2015 8:07:08 GMT -5
|
|
|
Post by ezrasfund on Jun 4, 2015 8:54:35 GMT -5
This is a bit upsetting, as it is exactly the study that is needed with Afrezza. I think a mealtime insulin would prove more effective with Afrezza than with the once daily Toujeo, as it is the mealtime response that T2's lose first.
I e-mailed Matt with a link to this article. I would like to CC Hakan and Al. Anyone have their e-mail addresses at hand? Or better yet, send an e-mail to them and to SNY, too.
|
|